These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29775957)

  • 1. How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis.
    Levin FR; Choi CJ; Pavlicova M; Mariani JJ; Mahony A; Brooks DJ; Nunes EV; Grabowski J
    Drug Alcohol Depend; 2018 Jul; 188():135-140. PubMed ID: 29775957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
    Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
    JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence.
    Notzon DP; Mariani JJ; Pavlicova M; Glass A; Mahony AL; Brooks DJ; Grabowski J; Levin FR
    Am J Addict; 2016 Dec; 25(8):666-672. PubMed ID: 28051838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.
    Weisler RH; Biederman J; Spencer TJ; Wilens TE; Faraone SV; Chrisman AK; Read SC; Tulloch SJ
    CNS Spectr; 2006 Aug; 11(8):625-39. PubMed ID: 16871129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study.
    Spencer TJ; Adler LA; Weisler RH; Youcha SH
    J Clin Psychiatry; 2008 Sep; 69(9):1437-48. PubMed ID: 19012813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder.
    Mattingly G; Arnold V; Yan B; Yu M; Robertson B
    J Child Adolesc Psychopharmacol; 2020 Nov; 30(9):549-557. PubMed ID: 33185468
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Adler LA; Robertson B; Chen J; Sarkis E
    J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):427-438. PubMed ID: 32423239
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design.
    Wigal T; Brams M; Frick G; Yan B; Madhoo M
    Postgrad Med; 2018 Jun; 130(5):481-493. PubMed ID: 29809075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Hoc Analyses of the Effects of Baseline Sleep Quality on SHP465 Mixed Amphetamine Salts Extended-Release Treatment Response in Adults with Attention-Deficit/Hyperactivity Disorder.
    Surman CBH; Robertson B; Chen J; Cortese S
    CNS Drugs; 2019 Jul; 33(7):695-706. PubMed ID: 31228031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment.
    Wigal T; Childress A; Frick G; Yan B; Wigal S; Madhoo M
    Postgrad Med; 2018 Jan; 130(1):111-121. PubMed ID: 29087231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.
    Stein MA; Waldman ID; Charney E; Aryal S; Sable C; Gruber R; Newcorn JH
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):581-8. PubMed ID: 22136094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension.
    Wilens TE; Zusman RM; Hammerness PG; Podolski A; Whitley J; Spencer TJ; Gignac M; Biederman J
    J Clin Psychiatry; 2006 May; 67(5):696-702. PubMed ID: 16841618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
    Weisler RH; Greenbaum M; Arnold V; Yu M; Yan B; Jaffee M; Robertson B
    CNS Drugs; 2017 Aug; 31(8):685-697. PubMed ID: 28712074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder.
    Biederman J; Lopez FA; Boellner SW; Chandler MC
    Pediatrics; 2002 Aug; 110(2 Pt 1):258-66. PubMed ID: 12165576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mixed amphetamine salt extended release (Adderall XR, Max-XR) as an adjunctive to SSRIS or SNRIS in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety: an open-label study.
    Gabriel A
    Atten Defic Hyperact Disord; 2010 Jun; 2(2):87-92. PubMed ID: 21432593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD.
    Goodman DW; Ginsberg L; Weisler RH; Cutler AJ; Hodgkins P
    CNS Spectr; 2005 Dec; 10(12 Suppl 20):26-34. PubMed ID: 16344838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of lisdexamfetamine and mixed amphetamine salts immediate release in adult ADHD: results of a crossover design clinical trial.
    Adler LA; Alperin S; Leon T; Faraone S
    Postgrad Med; 2014 Sep; 126(5):17-24. PubMed ID: 25295646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.